- Creso Pharma (CPH) has expanded its agreement with Route2 Pharm to allow its products to be distributed in Ecuador
- Route2 is a subsidiary of Route2Health which has over 30 years of experience producing and distributing herbal remedies and dietary supplements
- Ecuador is an ideal market to enter into as it recently passed legislation for the production and consumption of cannabis for medicinal treatment
- The Latin America and Caribbean cannabis market has 655 million users and is expected to be valued at over US$300 million (around A$391 million) by 2024
Read the Full Article on The Market Herald here
Creso Pharma (CPH) has expanded its agreement with Route2 Pharm...
Add to My Watchlist
What is My Watchlist?